An investigation into the factors affecting investigator-initiated trial start-up in Ireland
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An investigation into the factors affecting investigator-initiated trial start-up in Ireland ; volume:21 ; number:1 ; day:23 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Trials ; 21, Heft 1 (23.11.2020), 1-11, 12.2020
- Urheber
-
Leddy, Lauren
Sukumar, Prasanth
O’Sullivan, Lydia
Keane, Fionnuala
Devane, Declan
Doran, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-04893-z
- URN
-
urn:nbn:de:101:1-2021010321021863225152
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leddy, Lauren
- Sukumar, Prasanth
- O’Sullivan, Lydia
- Keane, Fionnuala
- Devane, Declan
- Doran, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)